There are no OTC medications approved for the treatment of COPD. The condition is managed with a combination of short-acting bronchodilators like albuterol for acute symptoms and long-acting ...

Adults with COPD who used inhaled corticosteroids for more than 24 months faced higher risks for diabetes, osteoporosis, ...

Inhaled corticosteroids (ICS) are commonly prescribed for chronic obstructive pulmonary disease (COPD), but not recommended as first-line treatment unless patients have asthma/COPD overlap or frequent ...

AstraZeneca may mount a challenge to GlaxoSmithKline’s three-in-one inhaler for chronic obstructive pulmonary disease (COPD ... as well as PT009 – a combination of budesonide formoterol ...

A further 500 were given the triple combination but in two inhalers. COPD is term used to describe a number of progressive lung diseases such as emphysema. The main cause is smoking, although the ...

Inhaled corticosteroids (ICS), short ... AstraZeneca), which are ICS–LABA combinations, are other popular COPD drugs. A major limitation with the current corticosteroid therapy is that they ...

Teva has launched new digital inhaler and drug combination in the US, containing built-in sensors that connect to a phone to help manage asthma and COPD symptoms. Israel-based Teva said the ...

AstraZeneca recently announced the completion of clinical studies for a next-generation propellant (NGP) version of its chronic obstructive pulmonary disease (COPD) inhaler, Breztri. This new ...